Zinc, Not Insulin, Regulates the Rat Alpha-cell Response to Hypoglycemia in Vivo
Overview
Affiliations
The intra-islet insulin hypothesis proposes that the decrement in beta-cell insulin secretion during hypoglycemia provides an activation signal for alpha-cells to release glucagon. A more recent hypothesis proposes that zinc atoms suppress glucagon secretion via their ability to open alpha-cell ATP-sensitive K(+) channels. Since insulin binds zinc, and zinc is co-secreted with insulin, we tested whether decreased zinc delivery to the alpha-cell activates glucagon secretion. In streptozotocin-induced diabetic Wistar rats, we observed that switching off intrapancreatic artery insulin infusions in vivo during hypoglycemia greatly improved glucagon secretion (area under the curve [AUC]: control group 240 +/- 261 and experimental group 4,346 +/- 1,259 pg x ml(-1) x 90 min(-1); n = 5, P < 0.02). Switching off pancreatic artery infusions of zinc chloride during hypoglycemia also improved the glucagon response (AUC: control group 817 +/- 107 and experimental group 3,445 +/- 573 pg x ml(-1) x 90 min(-1); n = 6, P < 0.01). However, switching off zinc-free insulin infusions had no effect. Studies of glucose uptake in muscle and liver cell lines verified that the zinc-free insulin was biologically active. We conclude that zinc atoms, not the insulin molecule itself, provide the switch-off signal from the beta-cell to the alpha-cell to initiate glucagon secretion during hypoglycemia.
Hypoglycemia Unawareness-A Review on Pathophysiology and Clinical Implications.
Holzen L, Schultes B, Meyhofer S, Meyhofer S Biomedicines. 2024; 12(2).
PMID: 38397994 PMC: 10887081. DOI: 10.3390/biomedicines12020391.
Campbell J, Muller T, Finan B, DiMarchi R, Tschop M, DAlessio D Cell Metab. 2023; 35(9):1519-1529.
PMID: 37591245 PMC: 10528201. DOI: 10.1016/j.cmet.2023.07.010.
α-cell electrophysiology and the regulation of glucagon secretion.
Gao R, Acreman S, Ma J, Abdulkader F, Wendt A, Zhang Q J Endocrinol. 2023; 258(2).
PMID: 37159865 PMC: 10326640. DOI: 10.1530/JOE-22-0295.
The past, present, and future physiology and pharmacology of glucagon.
Capozzi M, DAlessio D, Campbell J Cell Metab. 2022; 34(11):1654-1674.
PMID: 36323234 PMC: 9641554. DOI: 10.1016/j.cmet.2022.10.001.
New Developments in Glucagon Treatment for Hypoglycemia.
Story L, Wilson L Drugs. 2022; 82(11):1179-1191.
PMID: 35932416 DOI: 10.1007/s40265-022-01754-8.